<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph-family" /><meta name="keywords" content="Hepatitis B: immunisation: vaccine" /><meta name="IX" content="Hepatitis B: immunisation: vaccine" /><title>Hepatitis B vaccine: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="6488.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="6488.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=6488.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2081.htm">14 Immunological products and vaccines</a> &gt; <a href="6454.htm">14.4 Vaccines and antisera</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="201189.htm" title="Previous: HEPATITIS A VACCINE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="201190.htm" title="Next: HEPATITIS B VACCINE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a381051.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hepatitis B Immune Globulin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Serums, Toxoids, and Vaccines 80:00 &gt; Serums 80:04</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a381052.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hepatitis B Vaccine</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Serums, Toxoids, and Vaccines 80:00 &gt; Vaccines 80:12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/12818-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Hepatitis b vaccines</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: H &gt; Interactions of Hepatitis b vaccines</p></div></li></ul><ul><li><h3>British National Formulary (16)</h3></li><li><a href="82000.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Zeffix®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors &gt; LAMIVUDINE</p></div></li><li><a href="106524.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">TENOFOVIR DISOPROXIL</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors</p></div></li><li><a href="106525.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Viread®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors &gt; TENOFOVIR DISOPROXIL</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (16)</a></li></ul><ul><li><h3>BNF for Children (16)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/82000.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Zeffix®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors &gt; LAMIVUDINE</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/129085.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.3 Viral hepatitis</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/4257.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Use of corticosteroids</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.3 Corticosteroids &gt; 6.3.2 Glucocorticoid therapy</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (16)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (8)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/20692-r.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Diphtheria, Tetanus, and Hepatitis B Vaccines</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Vaccines Immunoglobulins and Antisera &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/20261-r.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Diphtheria, Tetanus, Pertussis, Haemophilus Influenzae, and Hepatitis B Vaccines</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Vaccines Immunoglobulins and Antisera &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/10051-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Diphtheria, Tetanus, Pertussis, and Hepatitis B Vaccines</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Vaccines Immunoglobulins and Antisera &gt; Drug Monographs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (8)</a></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E14E3E0R0D2096.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Hepatitis b vaccines</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; H</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_6488">Hepatitis B vaccine</h1><?highlighter on?><div id="pC" class="jN"><div><p><b>Hepatitis B vaccine</b> contains
inactivated hepatitis B virus surface antigen (HBsAg) adsorbed onto <span>aluminium hydroxide</span> adjuvant. It is made biosynthetically
using recombinant DNA technology. The vaccine is used in individuals
at high risk of contracting hepatitis B.</p><p>In the UK, groups at high-risk of hepatitis B include:</p><ul class="cBF"><li><p class="cQ">parenteral drug misusers, their sexual partners, and household
contacts; other drug misusers who are likely to ‘progress’ to injecting;</p></li><li><p class="cQ">individuals who change sexual partners frequently;</p></li><li><p class="cQ">close family contacts of a case or individual with chronic
hepatitis B infection;</p></li><li><p class="cQ">babies whose mothers have had acute hepatitis B during
pregnancy <i>or</i> are positive for hepatitis B surface
antigen (regardless of e-antigen markers); hepatitis B vaccination
is started immediately on delivery and <i>hepatitis B immunoglobulin</i> (see  section 14.5.2 under <a title="BNF:monograph-family: Hepatitis B" href="202715.htm#_202715">Hepatitis B</a>) given at the
same time (but preferably at a different site). Babies whose mothers
are positive for hepatitis B surface antigen and for e-antigen antibody
should receive the vaccine only (but babies weighing 1.5 kg or less
should also receive the immunoglobulin regardless of the mother’s
e-antigen antibody status);</p></li><li><p class="cQ">individuals with haemophilia, those receiving regular
blood transfusions or blood products, and carers responsible for the
administration of such products;</p></li><li><p class="cQ">patients with chronic renal failure including those on
haemodialysis. Haemodialysis patients should be monitored for antibodies
annually and re-immunised if necessary. Home carers (of dialysis patients)
should be vaccinated;</p></li><li><p class="cQ">individuals with chronic liver disease;</p></li><li><p class="cQ">healthcare personnel (including trainees) who have direct
contact with blood or blood-stained body fluids or with patients’
tissues;</p></li><li><p class="cQ">laboratory staff who handle material that may contain
the virus;</p></li><li><p class="cQ">other occupational risk groups such as morticians and
embalmers;</p></li><li><p class="cQ">staff and patients of day-care or residential accommodation
for those with severe learning difficulties;</p></li><li><p class="cQ">staff and inmates of custodial institutions;</p></li><li><p class="cQ">those travelling to areas of high or intermediate prevalence
who are at increased risk or who plan to remain there for lengthy
periods (see <a title="target-block: Hepatitis B vaccine, International travel" href="6558.htm#_120021">section 14.6</a>);</p></li><li><p class="cQ">families adopting children from countries with a high
or intermediate prevalence of hepatitis B;</p></li><li><p class="cQ">foster carers and their families.</p></li></ul><p>Different immunisation schedules for hepatitis B vaccine are
recommended for specific circumstances (see under individual preparations).
Generally, three or four doses are required for primary immunisation;
an ‘accelerated schedule’ is recommended for pre-exposure prophylaxis
in high-risk groups where rapid protection is required, and for post-exposure
prophylaxis (see below).</p><p>Immunisation may take up to 6 months to confer adequate protection;
the duration of immunity is not known precisely, but a single booster
5 years after the primary course may be sufficient to maintain immunity
for those who continue to be at risk.</p><p>Immunisation does not eliminate the need for commonsense precautions
for avoiding the risk of infection from known carriers by the routes
of infection which have been clearly established, consult <i>Guidance for Clinical Health Care Workers: Protection against Infection
with Blood-borne Viruses</i> (available at <a href="http://www.dh.gov.uk" title="external link">www.dh.gov.uk</a>). Accidental
inoculation of hepatitis B virus-infected blood into a wound, incision,
needle-prick, or abrasion may lead to infection, whereas it is unlikely
that indirect exposure to a carrier will do so.</p><p>Following significant exposure to hepatitis B, an accelerated
schedule, with the second dose given 1 month, and the third dose 2
months after the first dose, is recommended. For those at continued
risk, a fourth dose should be given 12 months after the first dose.
More detailed guidance is given in the handbook <a title="BNF:target-block: Handbook of immunisation against infectious disease" href="6451.htm#_202661"><i>Immunisation against
Infectious Disease</i></a>.</p><p>Specific <b>hepatitis B immunoglobulin</b> (‘HBIG’)
is available for use with the vaccine in those accidentally inoculated
and in neonates at special risk of infection (<a title="BNF:monograph-family: Hepatitis B" href="202715.htm#_202715">section 14.5.2</a>).</p><p>A combined hepatitis A and hepatitis B vaccine is also available.</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_201190"><a href="201190.htm" title="HEPATITIS B VACCINE">HEPATITIS B VACCINE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="201189.htm">Previous: HEPATITIS A VACCINE </a> | <a class="top" href="6488.htm#">Top</a> | <a accesskey="]" href="201190.htm">Next: HEPATITIS B VACCINE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>